other_material
confidence high
sentiment neutral
materiality 0.50
Predictive Oncology grants 124,959 RSUs to CEO and 97,000 RSUs to Interim CFO
Axe Compute Inc.
- CEO Raymond F. Vennare receives 124,959 RSUs; Interim CFO Josh Blacher receives 97,000 RSUs.
- RSUs vest fully on October 31, 2025, subject to continued service through that date.
- Grants made under the 2024 Equity Incentive Plan; form of award agreement filed as Exhibit 10.1.
- Each RSU represents the right to receive one share of common stock upon vesting.
item 5.02item 9.01